Medical news of Remedium.ru portal is the most update information on pharmaceutical and medical equipment market

Journals

REMEDIUM

The periodical about the pharmaceutical and medical equipment markets

ROSSIYSKIE APTEKI

(Russian pharmacies) - specialized periodical edition for pgarmacy professionals

MEDITSINSKY SOVET

Medical Council - Scientific Journal for Physicians


Home / News

14.12.2016

Besins Healthcare to start production of pregnancy drugs in Russia

Pharmaceutical giant Besins Healthcare has signed an agreement with local authorities to build a drug manufacturing plant in the Yaroslav Region. The Belgian company is expected to invest $8 million in the project.

Besins Healthcare SA's representative office in Russia signed an agreement with the Yaroslavl Region government at the end of November. Source: Kommersant

The pharmaceutical company Besins Healthcare SA will build an integrated factory in Yaroslavl (250 miles north of Moscow) for producing Utrogestan, a drug to prevent premature births and miscarriages. The company’s representative office in Russia signed an agreement with the Yaroslavl Region government at the end of November. The news was announced by deputy chairman of the regional government Maxim Avdeyev at an itinerant session of the St. Petersburg International Economic Forum “Russian regions: New points of growth,” held in early December.

500 million rubles ($8 million) will be invested in the project. “These are the investor’s own funds. The new production will make it possible to replace a considerable portion of imported medicines,” Avdeyev told RBTH.

According to the signed agreement, the investor will begin the design phase in January 2017, with construction expected to be completed by the end of 2017, Avdeyev said. Provided all product trials are successful, manufacturing will start in late 2017 or early 2018, he added.

Besins Healthcare SA specializes in the production of original pharmaceuticals and food supplements for men’s and women’s health. The company has four plants in France, Belgium and Monaco.

Several pharmaceutical plants are already located in Yaroslavl Region, including the Israeli generics manufacturer Teva; a major Japanese manufacturer, Takeda; as well as Russian companies R-Pharm, Pharmoslavl, Vitapharma, and NTpharma. Avdeyev pointed out that the region offers many opportunities for investors, such convenient railroad and motorway links with Moscow, a river port and an airport with good potential, as well as a successful system for training personnel.



Source:  www.rbth.com

Remedium group

REMEDIUM

publishing house

CLIFAR

programmer of electronic software products

R-PRESS

advertisement agency

REPRENT

rent-a-rep company